Are randomized trials obsolete or more important than ever in the genomic era?
Open Access
- 1 January 2013
- journal article
- Published by Springer Nature in Genome Medicine
- Vol. 5 (4) , 32
- https://doi.org/10.1186/gm436
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Mega-Trials for BlockbustersPublished by American Medical Association (AMA) ,2013
- Systems pharmacology, pharmacogenetics, and clinical trial design in network medicineWires Systems Biology and Medicine, 2012
- Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trialThe Lancet, 2012
- Improving Validation Practices in “Omics” ResearchScience, 2011
- The N-Of-1 Clinical Trial: The Ultimate Strategy For Individualizing Medicine?Personalized Medicine, 2011
- The Use of Genomics in Clinical Trial DesignClinical Cancer Research, 2008
- A Critical Appraisal of the Scientific Basis of Commercial Genomic Profiles Used to Assess Health Risks and Personalize Health InterventionsAmerican Journal of Human Genetics, 2008
- HLA-B*5701 Screening for Hypersensitivity to AbacavirNew England Journal of Medicine, 2008